In patients with ARDS and treatment with veno-venous ECMO, high endogenous plasma concentrations of Hp could compensate for the negative effects of disease- and therapy-associated high plasma concentrations of CFH [17]. The gene discussed is CFH; the disease is acute respiratory distress syndrome.